VirxSys' Series C Round

VirxSys raised a round of funding on September 16, 2002. Investors include Johns Hopkins University.

VIRxSYS is a privately-held biotechnology company with proprietary platform technologies with which the Company intends to develop therapies for serious human diseases. The Company's platform technolo…

Articles about VirxSys' Series C Round: